On the public citation graph
Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma
0 signed · 75 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/mc.20389openalex-snapshot
DLC‐1 suppresses non‐small cell lung cancer growth and invasion by RhoGAP‐dependent and independent mechanisms
inferredcites →https://doi.org/10.1007/s00432-003-0440-zopenalex-snapshot
Analysis of DLC-1 expression in human breast cancer
inferredcites →https://doi.org/10.1007/s10147-010-0157-3openalex-snapshot
Oral premalignant lesions: from a clinical perspective
inferredcites →https://doi.org/10.1007/s10147-010-0169-zopenalex-snapshot
Oral premalignant lesions: from the pathological viewpoint
inferredcites →https://doi.org/10.1007/s10555-008-9167-2openalex-snapshot
Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility
inferredcites →https://doi.org/10.1007/s11033-010-0311-zopenalex-snapshot
DLC-1 as a modulator of proliferation, apoptosis and migration in Burkitt’s lymphoma cells
inferredcites →https://doi.org/10.1007/s11912-010-0150-zopenalex-snapshot
Oral Dysplasia: Biomarkers, Treatment, and Follow-up
inferredcites →https://doi.org/10.1016/j.bbrc.2007.01.121openalex-snapshot
DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.biocel.2007.04.008openalex-snapshot
Deleted in liver cancer-1 (DLC-1): A tumor suppressor not just for liver
inferredcites →https://doi.org/10.1016/j.canep.2009.08.011openalex-snapshot
Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers
inferredcites →https://doi.org/10.1016/j.canlet.2006.08.019openalex-snapshot
Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma
inferredcites →https://doi.org/10.1016/j.canlet.2009.03.025openalex-snapshot
Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma
inferredcites →https://doi.org/10.1016/j.cdp.2007.02.005openalex-snapshot
Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines
inferredcites →https://doi.org/10.1016/j.tcb.2004.05.003openalex-snapshot
GAP control: regulating the regulators of small GTPases
inferredcites →https://doi.org/10.1016/j.tripleo.2006.10.015openalex-snapshot
Management of oral epithelial dysplasia: a review
inferredcites →https://doi.org/10.1016/j.yexcr.2009.05.022openalex-snapshot
Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration
inferredcites →https://doi.org/10.1016/s0027-5107(03)00081-2openalex-snapshot
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study
inferredcites →https://doi.org/10.1016/s0165-4608(02)00674-xopenalex-snapshot
Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers
inferredcites →https://doi.org/10.1021/bi9000936openalex-snapshot
Characterization of DLC1-SAM Equilibrium Unfolding at the Amino Acid Residue Level
inferredcites →https://doi.org/10.1021/pr7007797openalex-snapshot
Prognostic Significance of Head-and-Neck Cancer Biomarkers Previously Discovered and Identified Using iTRAQ-Labeling and Multidimensional Liquid Chromatography−Tandem Mass Spectrometry
inferredcites →https://doi.org/10.1021/pr800501jopenalex-snapshot
iTRAQ-Multidimensional Liquid Chromatography and Tandem Mass Spectrometry-Based Identification of Potential Biomarkers of Oral Epithelial Dysplasia and Novel Networks between Inflammation and Premalignancy
inferredcites →https://doi.org/10.1038/cgt.2008.13openalex-snapshot
Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy
inferredcites →https://doi.org/10.1038/onc.2010.576openalex-snapshot
A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors
inferredcites →https://doi.org/10.1038/sj.onc.1207246openalex-snapshot
Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells
inferredcites →https://doi.org/10.1038/sj.onc.1207291openalex-snapshot
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
inferredcites →https://doi.org/10.1053/j.gastro.2010.06.051openalex-snapshot
Akt Phosphorylation of Deleted in Liver Cancer 1 Abrogates Its Suppression of Liver Cancer Tumorigenesis and Metastasis
inferredcites →https://doi.org/10.1053/j.gastro.2010.08.016openalex-snapshot
DLC1 and Liver Cancer: The Akt Connection
inferredcites →https://doi.org/10.1073/pnas.0703033104openalex-snapshot
Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities
inferredcites →https://doi.org/10.1074/jbc.m800617200openalex-snapshot
Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell Morphology and Migration
inferredcites →https://doi.org/10.1074/mcp.m700500-mcp200openalex-snapshot
Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry
inferredcites →https://doi.org/10.1089/gte.2007.0121openalex-snapshot
The DLC-1 −29A/T Polymorphism Is Not Associated with Nasopharyngeal Carcinoma Risk in Chinese Population
inferredcites →https://doi.org/10.1097/cad.0b013e32834249baopenalex-snapshot
New advances in molecular approaches to head and neck squamous cell carcinoma
inferredcites →https://doi.org/10.1101/gad.1672608openalex-snapshot
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma
inferredcites →https://doi.org/10.1101/gad.1691408openalex-snapshot
DLC1: a significant GAP in the cancer genome
inferredcites →https://doi.org/10.1111/j.0006-341x.2005.030814.xopenalex-snapshot
Survival Model Predictive Accuracy and ROC Curves
inferredcites →https://doi.org/10.1111/j.1478-3231.2009.02133.xopenalex-snapshot
Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma
inferredcites →https://doi.org/10.1111/j.1582-4934.2007.00098.xopenalex-snapshot
DLC‐1:a Rho GTPase‐activating protein and tumour suppressor
inferredcites →https://doi.org/10.1111/j.1600-0714.2007.00496.xopenalex-snapshot
Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco – a review
inferredcites →https://doi.org/10.1111/j.1600-0714.2007.00582.xopenalex-snapshot
Nomenclature and classification of potentially malignant disorders of the oral mucosa
inferredcites →https://doi.org/10.1111/j.1600-0714.2007.00584.xopenalex-snapshot
Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement
inferredcites →https://doi.org/10.1111/j.1601-0825.2009.01642.xopenalex-snapshot
Is early diagnosis of oral cancer a feasible objective? Who is to blame for diagnostic delay?
inferredcites →https://doi.org/10.1111/j.1601-0825.2011.01789.xopenalex-snapshot
Genetics/epigenetics of oral premalignancy: current status and future research*
inferredcites →https://doi.org/10.1111/j.1745-7270.2006.00164.xopenalex-snapshot
Genetic and Epigenetic Alterations of DLC-1, a Candidate Tumor Suppressor Gene, in Nasopharyngeal Carcinoma
inferredcites →https://doi.org/10.1158/0008-5472.can-04-3043openalex-snapshot
The RhoGAP Protein DLC-1 Functions as a Metastasis Suppressor in Breast Cancer Cells
inferredcites →https://doi.org/10.1158/0008-5472.can-05-1318openalex-snapshot
Rho GTPase-Activating Protein Deleted in Liver Cancer Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1158/0008-5472.can-08-0984openalex-snapshot
Deleted in Liver Cancer 1 Controls Cell Migration through a Dia1-Dependent Signaling Pathway
inferredcites →https://doi.org/10.1158/0008-5472.can-10-1174openalex-snapshot
DLC1 Negatively Regulates Angiogenesis in a Paracrine Fashion
inferredcites →https://doi.org/10.1158/0008-5472.can-10-2158openalex-snapshot
DLC1 Interaction with S100A10 Mediates Inhibition of In Vitro Cell Invasion and Tumorigenicity of Lung Cancer Cells through a RhoGAP-Independent Mechanism
inferredcites →https://doi.org/10.1158/1078-0432.ccr-05-1906openalex-snapshot
Aberrant Methylation and Deacetylation of Deleted in Liver Cancer-1 Gene in Prostate Cancer: Potential Clinical Applications
inferredcites →https://doi.org/10.1159/000218524openalex-snapshot
Expression of DLC-1 in Clear Cell Renal Cell Carcinoma: Prognostic Significance for Progression and Metastasis
inferredcites →https://doi.org/10.1227/01.neu.0000325488.72518.9eopenalex-snapshot
IDENTIFICATION OF THE DELETED IN LIVER CANCER 1 GENE, DLC1, AS A CANDIDATE MENINGIOMA TUMOR SUPPRESSOR
inferredcites →https://doi.org/10.1242/jcs.027482openalex-snapshot
The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration
inferredcites →https://doi.org/10.1242/jcs.036251openalex-snapshot
DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling
inferredcites →https://doi.org/10.2741/1529openalex-snapshot
S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors
inferredcites →https://doi.org/10.3892/ijo_00000580openalex-snapshot
Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: Perspectives for therapeutics
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.5061160openalex-extracted
A Pathomics-Based Deep Learning Model for Predicting Oral Squamous Cell Carcinoma Prognosis
inferred← citeshttps://doi.org/10.1007/978-981-15-6499-4_3openalex-snapshot
Recent Advances in Oral Cancer Research
inferred← citeshttps://doi.org/10.1007/s00795-017-0177-4openalex-snapshot
SUOX is negatively associated with multistep carcinogenesis and proliferation in oral squamous cell carcinoma
inferred← citeshttps://doi.org/10.1007/s12032-015-0525-yopenalex-snapshot
Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein–Barr virus-associated gastric carcinomas
inferred← citeshttps://doi.org/10.1007/s12672-026-04599-9openalex-snapshot
Establishment and validation of a prognostic model for oral squamous cell carcinoma based on ribosomal and apoptosis-related gene expression
inferred← citeshttps://doi.org/10.1007/s13277-013-0813-0openalex-snapshot
DLC1 as a regulator of proliferation, invasion, cell cycle, and apoptosis in cutaneous squamous cell carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115104openalex-snapshot
Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?
inferred← citeshttps://doi.org/10.1016/j.oraloncology.2017.07.003openalex-snapshot
Prognostic biomarkers in oral squamous cell carcinoma: A systematic review
inferred← citeshttps://doi.org/10.1038/bjc.2014.415openalex-snapshot
Prognostic significance of epithelial–mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray
inferred← citeshttps://doi.org/10.1038/modpathol.2013.223openalex-snapshot
DLC1 expression is reduced in human cutaneous melanoma and correlates with patient survival
inferred← citeshttps://doi.org/10.1039/d0fo00996bopenalex-snapshot
Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration via regulation of the DLC1/TCTP/Cdc42 pathway
inferred← citeshttps://doi.org/10.1158/0008-5472.can-12-0777openalex-snapshot
Functional Interaction of Tumor Suppressor DLC1 and Caveolin-1 in Cancer Cells
inferred← citeshttps://doi.org/10.1158/0008-5472.can-12-2368openalex-snapshot
Inactivation of the Dlc1 Gene Cooperates with Downregulation of p15INK4b and p16Ink4a , Leading to Neoplastic Transformation and Poor Prognosis in Human Cancer
inferred← citeshttps://doi.org/10.1186/s12957-021-02423-yopenalex-snapshot
A systematic review of proteomic biomarkers in oral squamous cell cancer
inferred← citeshttps://doi.org/10.17795/ijcp-4383openalex-snapshot
Rhabdomyosarcoma of Cervix: A Case Report
inferred← citeshttps://doi.org/10.3205/iprs000190openalex-snapshot
Metabolic biomarker in oral squamous cell carcinoma – a comprehensive review
inferred← citeshttps://doi.org/10.3892/mmr.2015.4173openalex-snapshot
Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.16900834openalex-snapshot
Additional file 1 of A systematic review of proteomic biomarkers in oral squamous cell cancer
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.